In silico prediction of GRP78-CRIPTO binding sites to improve therapeutic targeting in glioblastoma
Abstract Glioblastoma multiforme (GBM) is one of the most malignant tumors in central nervous system (CNS) tumors. The glucose-regulated protein 78 (GRP78) and CRIPTO (Cripto-1), a protein that belongs to the EGF-CFC (epidermal growth factor cripto-1 FRL-1 cryptic) family, are overexpressed in GBM....
Saved in:
| Main Authors: | Mahmoud E. Rashwan, Mahrous R. Ahmed, Abdo A. Elfiky |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-00125-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
GRP78 Nanobody‐Directed Immunotoxin Activates Innate Immunity Through STING Pathway to Synergize Tumor Immunotherapy
by: Huifang Wang, et al.
Published: (2025-05-01) -
Efficacy of systemic temozolomide‐activated phage‐targeted gene therapy in human glioblastoma
by: Justyna Magdalena Przystal, et al.
Published: (2019-02-01) -
The Differential Expressions and Associations of Intracellular and Extracellular GRP78/Bip with Disease Activity and Progression in Rheumatoid Arthritis
by: Guoyin Liu, et al.
Published: (2025-01-01) -
Cripto-1 and Cripto-3 differential expression pattern in human placenta, umbilical cord and fetal tissues suggests new functions for these proteins
by: Josune García-Sanmartín, et al.
Published: (2025-08-01) -
Fisetin may protect early porcine embryos from oxidative stress by down-regulating GRP78 levels
by: Xiu-Wen Yuan, et al.
Published: (2025-03-01)